|
| (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine Basic information |
Product Name: | (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine | Synonyms: | 1-(4-phenyl-1H-imidazol-2-yl)-ethylamine;1H-Imidazole-2-methanamine, α-methyl-4-phenyl-, (αS)-;1H-Imidazole-2-methanamine, α-methyl-5-phenyl-, (αS)-;(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine;(S)-1-(5-PHENYL-1H-IMIDAZOL-2-YL)ETHANAMINE;(alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine;(S)-alpha-Methyl-4-phenyl-1H
-imidazole-2-methanamine;EOS-61915 | CAS: | 864825-23-0 | MF: | C11H13N3 | MW: | 187.24 | EINECS: | 1592732-453-0 | Product Categories: | | Mol File: | 864825-23-0.mol | |
| (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine Chemical Properties |
Melting point | 136-138°C | Boiling point | 422.1±28.0 °C(Predicted) | density | 1.145±0.06 g/cm3 (20 ºC 760 Torr) | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 13.16±0.10(Predicted) | form | Solid | color | PaleYellow |
| (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine Usage And Synthesis |
Description | (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine is a pharmaceutical intermediate ingredient used in the preparation of Eluxadoline drugs for the treatment of adults suffering from irritable bowel syndrome with diarrhoea (IBS-D). | Uses | (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine is an intermediate used to prepare a δ-opioid antagonists/μ-opioid agonists used in potential therapy for diarrhea-predominant irritable bowel syndrome (IBS-d). |
| (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine Preparation Products And Raw materials |
|